Replay available

Zymeworks Inc. (ZYME) Q4 2025 Earnings Call

Zymeworks Inc. (NASDAQ: ZYME) Q4 2025 earnings conference call, held 2026-03-02. Replay captured from the company's public earnings webcast.

Mon, March 2, 2026 at 8:30 AMendedReplay
Zymeworks Inc. (ZYME) Q4 2025 Earnings Call

Hosted by

Featured presenters

Shernell Elmander

Vice President of Investor Relations

Ken Galbraith

Chair, CEO, and Interim Chief Financial Officer

Bijal Desai

Senior Vice President of Finance

Dr. Sabine Mikan

Senior Vice President and Chief Medical Officer

Paul Moore

Chief Scientific Officer

Scott Pashtun

Acting Chief Investment Officer

Adam Shaywitz

Acting Chief Development Officer

Charles Zhu

Analyst, LifeSci Capital

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Zymeworks Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.635 Thank you for standing by. This is the conference operator. 00:00:03.635 -- 00:00:07.339 Welcome to DesignWorks' fourth quarter 2025 00:00:07.339 -- 00:00:12.525 results conference call and webcast. As a reminder, all participants are in listen-only 00:00:12.525 -- 00:00:15.268 mode, and the conference is being recorded. 00:00:15.268 -- 00:00:18.772 After the presentation, there will be an opportunity to ask questions. 00:00:18.772 -- 00:00:22.936 I would now like to turn the conference over to Shernell Elmander, Vice President of 00:00:22.936 -- 00:00:25.099 Investor Relations. Shernell, please go ahead. 00:00:25.099 -- 00:00:28.465 Thank you, operator, and good morning, everyone. 00:00:28.465 -- 00:00:33.111 Thank you for joining our fourth quarter 2025 results conference call. 00:00:33.111 -- 00:00:36.755 As usual, I'd like to remind you that we'll be making a number of forward-looking statements 00:00:36.755 -- 00:00:41.240 during this call, including without limitation, those forward-looking statements identified 00:00:41.240 -- 00:00:44.184 in our slides and the accompanying oral commentary. 00:00:44.184 -- 00:00:48.289 Forward-looking statements are based upon our current expectations and various assumptions 00:00:48.289 -- 00:00:52.554 and are subject to the risks and uncertainties, including those associated with the companies 00:00:52.554 -- 00:00:55.637 in our industry and at our stage of development. 00:00:55.637 -- 00:01:00.617 The discussion of these risks and uncertainties I refer you to the latest SEC findings 00:01:00.617 -- 00:01:04.481 as found on our website and as filed with the SEC. 00:01:04.481 -- 00:01:08.726 In a moment, I'll hand over the call to Ken Galbraith, our Chair, CEO, and Interim Chief 00:01:08.72...